Sleep-disordered breathing and epicardial adipose tissue in patients with heart failure.

[1]  S. Ryan.  Adipose tissue inflammation by intermittent hypoxia: mechanistic link between obstructive sleep apnoea and metabolic dysfunction , 2017, The Journal of physiology.

[2]  C. Snehalatha,et al.  Classification and Diagnosis of Diabetes , 2016 .

[3]  A. Hoes,et al.  2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. , 2016, European heart journal.

[4]  P. Gargiulo,et al.  Sleep-disordered breathing, impaired cardiac adrenergic innervation and prognosis in heart failure , 2016, Heart.

[5]  T. Münzel,et al.  Differences between perivascular adipose tissue surrounding the heart and the internal mammary artery: possible role for the leptin-inflammation-fibrosis-hypoxia axis , 2016, Clinical Research in Cardiology.

[6]  D. Leosco,et al.  Increased Epicardial Adipose Tissue Volume Correlates With Cardiac Sympathetic Denervation in Patients With Heart Failure. , 2016, Circulation research.

[7]  L. Velentza,et al.  CPAP therapy induces favorable short-term changes in epicardial fat thickness and vascular and metabolic markers in apparently healthy subjects with obstructive sleep apnea-hypopnea syndrome (OSAHS) , 2016, Sleep and Breathing.

[8]  D. Leosco,et al.  Epicardial adipose tissue has an increased thickness and is a source of inflammatory mediators in patients with calcific aortic stenosis. , 2015, International journal of cardiology.

[9]  A. Leite-Moreira,et al.  Influence of epicardial and visceral fat on left ventricular diastolic and systolic functions in patients after myocardial infarction. , 2014, The American journal of cardiology.

[10]  D. Leosco,et al.  Changes of plasma norepinephrine and serum N-terminal pro-brain natriuretic peptide after exercise training predict survival in patients with heart failure. , 2014, International journal of cardiology.

[11]  P. Lévy,et al.  Visceral white fat remodelling contributes to intermittent hypoxia-induced atherogenesis , 2013, European Respiratory Journal.

[12]  C. Moretti,et al.  Association of epicardial fat thickness with the severity of obstructive sleep apnea in obese patients. , 2013, International journal of cardiology.

[13]  W. Koch,et al.  Adrenergic Nervous System in Heart Failure: Pathophysiology and Therapy , 2013, Circulation research.

[14]  L. Donini,et al.  Relationships between Body Fat Distribution, Epicardial Fat and Obstructive Sleep Apnea in Obese Patients with and without Metabolic Syndrome , 2012, PloS one.

[15]  Sara Venturi,et al.  Inflammatory profile in subcutaneous and epicardial adipose tissue in men with and without diabetes , 2012, Heart and Vessels.

[16]  J. Pépin,et al.  The inflammatory preatherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition. , 2011, American journal of respiratory and critical care medicine.

[17]  Juan Valiente Mustelier,et al.  Parâmetros ecocardiográficos de deposição de gordura epicárdica e sua relação com doença arterial coronariana , 2011 .

[18]  J. V. Mustelier,et al.  Echocardiographic parameters of epicardial fat deposition and its relation to coronary artery disease. , 2011, Arquivos brasileiros de cardiologia.

[19]  Andre Lamy,et al.  Epicardial fat thickness and coronary artery disease correlate independently of obesity. , 2011, International journal of cardiology.

[20]  J. Vogt,et al.  Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. , 2011, European heart journal.

[21]  V. Somers,et al.  Consequences of comorbid sleep apnea in the metabolic syndrome--implications for cardiovascular risk. , 2010, Sleep.

[22]  G. Mancia,et al.  Reinforcement of the adrenergic overdrive in the metabolic syndrome complicated by obstructive sleep apnea , 2010, Journal of hypertension.

[23]  L. Sade,et al.  Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[24]  J. Floras,et al.  Relationship between sleep apnoea and mortality in patients with ischaemic heart failure , 2009, Heart.

[25]  S. Lantuejoul,et al.  Intermittent hypoxia induces early functional cardiovascular remodeling in mice. , 2008, American journal of respiratory and critical care medicine.

[26]  G. Tomlinson,et al.  Influence of obstructive sleep apnea on mortality in patients with heart failure. , 2007, Journal of the American College of Cardiology.

[27]  M. Matsuda,et al.  Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation , 2007, Diabetes.

[28]  Eun Mi Lee,et al.  Echocardiographic epicardial fat thickness and coronary artery disease. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[29]  C. Herder,et al.  Relationship between adipocyte size and adipokine expression and secretion. , 2007, The Journal of clinical endocrinology and metabolism.

[30]  R. Bonser,et al.  Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease , 2006, Cardiovascular diabetology.

[31]  Clodagh M Ryan,et al.  Pathogenesis of obstructive sleep apnea. , 2005, Journal of applied physiology.

[32]  S. Ando,et al.  Muscle Sympathetic Nerve Activity During Wakefulness in Heart Failure Patients With and Without Sleep Apnea , 2005, Hypertension.

[33]  Domenico Corradi,et al.  Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart , 2005, Nature Clinical Practice Cardiovascular Medicine.

[34]  Cheuk-Kwan Sun,et al.  Intermittent Hypoxia Induces Hyperlipidemia in Lean Mice , 2005, Circulation research.

[35]  F. Leonetti,et al.  Relation between epicardial adipose tissue and left ventricular mass. , 2004, The American journal of cardiology.

[36]  H. Tse,et al.  Endothelial function in obstructive sleep apnea and response to treatment. , 2004, American journal of respiratory and critical care medicine.

[37]  P. Picton,et al.  Influence of Cheyne-Stokes respiration on cardiovascular oscillations in heart failure. , 2003, American journal of respiratory and critical care medicine.

[38]  M. Naughton,et al.  Impact of sleep apnea on sympathetic nervous system activity in heart failure. , 2003, Chest.

[39]  M. Esler,et al.  Raised Sympathetic Nerve Activity in Heart Failure and Central Sleep Apnea Is Due to Heart Failure Severity , 2003, Circulation.

[40]  F. Leonetti,et al.  Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. , 2003, Obesity research.

[41]  L. Aloe,et al.  Subepicardial adipose tissue in human coronary atherosclerosis: another neglected phenomenon. , 2001, Atherosclerosis.

[42]  D. Papanicolaou,et al.  Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. , 2000, The Journal of clinical endocrinology and metabolism.

[43]  D. Papanicolaou,et al.  Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. , 1997, The Journal of clinical endocrinology and metabolism.

[44]  S. Kihara,et al.  Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects , 1997, Journal of internal medicine.

[45]  M. Naughton,et al.  Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. , 1995, American journal of respiratory and critical care medicine.

[46]  A. Xie,et al.  Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure , 1991, The Lancet.